Posters

TECNIS Eyhance: the clinical performance of a new intraocular lens (IOL) and its impact in quality of life

Poster Details

First Author: T.Loureiro PORTUGAL

Co Author(s): D. Lopes   A. Carreira   S. Barros   I. Machado   P. Campos   N. Campos     

Abstract Details

Purpose:

This study aimed to evaluate the clinical performance of the new TECNIS Eyhance IOL, model ICB00, and its impact in the quality of life and to compare with the TECNIS PCB00 monofocal IOL.

Setting:

Single-center prospective study including patients with bilateral indication for cataract surgery, below the age of 75, with astigmatism less than 1 diopter and with no history of ocular surgery.

Methods:

All patients were observed between the first and the second post-operative months and included the evaluation of corrected and uncorrected distance visual acuity (DVA) and photopic intermediate visual acuity (at 66cm), defocus curve and quality of life (Catquest-9SF questionnaire and global satisfaction).

Results:

A total of 60 eyes of 30 patients were included in each group. The uncorrected DVA was 20/22 in the ICB00 group and 20/20 in the PCB00. The corrected DVA was 20/20 in both groups. The monocular uncorrected intermediate visual acuity was 20/32 in the ICB00 group and 20/40 in the PCB00 (p=0.03). The defocus curve for the ICB00 model presented a plateau, with visual acuity superior to 20/40 up to 1.5D. The presence of dysphotopsias did not show any difference between groups. The ICB00 provided more global satisfaction and less difficulty in daily activities.

Conclusions:

The results of this study demonstrate a significant improvement in the intermediate visual acuity in the ICB00 group comparatively to the PCB00 control group, without compromising the distance visual acuity. It was also verified higher independence from glasses for intermediate-vision activities, such as working on a computer, for ICB00 IOL. Comparatively to other monofocal IOLs, the ICB00 stands out because of its innovative design and could revolutionize the monofocal IOLs, especially in a time there is a greater demand and expectation from patients for intermediate-vision activities

Financial Disclosure:

None